Table 2.
Clinical characteristics of patients at diagnosis (data are reported as median and IQR)
| All cohort (n = 96) | < 65 years (n = 83) | ≥ 65 years (n = 13) | P | |
|---|---|---|---|---|
| Gender | 40 male/56 female | 36 male/47 female | 4 male/9 female | 0.293a |
| GH (μg/L) nadir after OGTT | 6.9 (2.6–17.5) | 6.8 (3.6–21.9) | 6.9 (2.1–16) | 0.587b |
| IGF-1 (μg/L) | 715 (574–978) | 748 (602–996) | 600 (447–752) | 0.022b |
| IGF-1/normal IGF-1 (ULN) | 2.91 (2.26–3.6) | 3 (2.25–6.63) | 2.87 (2.14–3.12) | 0.371b |
| Micro−/macroadenoma | 20/60 (25%/75%) | 16/52 (24%/76%) | 4/8 (33%/67%) | 0.465a |
| Maximum diameter of adenoma | 15 (10–20) | 15 (11–20) | 11 (9–13) | 0.024b |
aPearson Chi-square test
bMann-Whitney test